News

NEWS

29th January, 2021


Pedanius Therapeutics shortlisted for the Bionow "AMR" Award 2020



Read on

21st June, 2022


Pedanius Therapeutics to present at Hamburg workshop on "Molecular Basis of Antibiotic Permeability in Gram-negative Bacteria"



Read on

18th November, 2020


Pedanius Therapeutics supporting World Antimicrobial Resistance Awareness Week 2020


Read on

26th February, 2021


Pedanius Therapeutics to present at OBN (UK) BioTuesday session on "How disruptive will RNA Technology be in Discovery and Development of Vaccines and Novel Therapies?"


Read on

9th June 2020


Pedanius Therapeutics attending the BIO Digital 2020 International Convention



Read on

28th April 2020


Pedanius Therapeutics attending the BioTrinity 2020 Life Sciences Conference



Read on

7th February, 2020


Pedanius Therapeutics to present at the 2020 BioInfect Conference




Read on

27th January, 2020


Pedanius Therapeutics LepB, RpsJ and LptD programmes demonstrates in vivo efficacy in Pneumonia caused by P. aeruginosa


Read on

10th January 2020


TheraIndx Lifesciences successfully delivers in vivo Pharmacology for Pedanius Therapeutics SBRI Contract to Tackle Antimicrobial Resistance in Humans 


Read on

28th November, 2019


Pedanius Therapeutics announces filing of an International PCT patent application relating to new bacterial RNA-targeted therapeutics


Read on

14th March, 2019


Pedanius Therapeutics presents at 

12th Berlin Conference on Life Sciences Novel Antimicrobials and AMR Diagnostics 2019



Read on

13th December, 2019


Pedanius Therapeutics FtsZ programme demonstrates in vivo efficacy in Pneumonia caused by A. baumannii



Read on

28th June, 2019


Key Organics successfully delivers Chemistry for Pedanius Therapeutics SBRI Contract to Tackle Antimicrobial Resistance in Humans 



Read on

22nd February, 2019


Pedanius Therapeutics secures £499,532 SBRI Contract to Tackle Antimicrobial Resistance in Humans

.


Read on

6th December, 2019


Pedanius Therapeutics AcpP programme demonstrates in vivo efficacy in UTI caused by E. coli



Read on

29th March, 2019


Pedanius Therapeutics announces a NBIC funded research collaboration with the University of Nottingham to tackle biofilms



Read on

16th February, 2019


Pedanius Therapeutics announces filing of a patent application relating to new bacterial RNA-targeted therapeutics



Read on